<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Angiotensin-converting enzyme (ACE) is a zinc-containing metallopeptidase that can elevate blood pressure by converting the inactive decapeptide angiotensin I to the effective vasoconstrictor angiotensin II, in addition, to degrading the hypotensive peptide bradykinin [
 <xref rid="B20-jcm-07-00283" ref-type="bibr" class="xref">20</xref>]. Due to the fundamental role of ACE in cardiovascular diseases, it has been an attractive target for drug design [
 <xref rid="B21-jcm-07-00283" ref-type="bibr" class="xref">21</xref>]. Up to date, no investigations have reported the ability of 
 <italic class="italic">T. bovei</italic>-derived EO to diminish the risk of hypertension and coronary heart disease by inactivating the enzymatic properties of ACE.
</p>
